147 related articles for article (PubMed ID: 25232493)
1. Methylated CpG site count of dapper homolog 1 (DACT1) promoter prediction the poor survival of gastric cancer.
Deng J; Liang H; Zhang R; Ying G; Xie X; Yu J; Fan D; Hao X
Am J Cancer Res; 2014; 4(5):518-27. PubMed ID: 25232493
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of the methylated cytosine-phosphate-guanine sites of protocadherin-10 promoter for evaluating the prognosis of gastric cancer.
Deng J; Liang H; Ying G; Dong Q; Zhang L; Yu J; Fan D; Hao X
J Am Coll Surg; 2014 Nov; 219(5):904-13. PubMed ID: 25260683
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the clinical feasibility: The direct bisulfite genomic sequencing for examination of methylated status of protocadherin10 (PCDH10) promoter to predict the prognosis of gastric cancer.
Hou YC; Deng JY; Zhang RP; Xie XM; Cui JL; Wu WP; Hao XS; Liang H
Cancer Biomark; 2015; 15(5):567-73. PubMed ID: 26406945
[TBL] [Abstract][Full Text] [Related]
4. Dapper homolog 1 is a novel tumor suppressor in gastric cancer through inhibiting the nuclear factor-κB signaling pathway.
Wang S; Kang W; Go MY; Tong JH; Li L; Zhang N; Tao Q; Li X; To KF; Sung JJ; Yu J
Mol Med; 2012 Dec; 18(1):1402-11. PubMed ID: 23073659
[TBL] [Abstract][Full Text] [Related]
5. Applicability of the methylated CpG sites of paired box 5 (PAX5) promoter for prediction the prognosis of gastric cancer.
Deng J; Liang H; Zhang R; Dong Q; Hou Y; Yu J; Fan D; Hao X
Oncotarget; 2014 Sep; 5(17):7420-30. PubMed ID: 25277182
[TBL] [Abstract][Full Text] [Related]
6. Poor survival is associated with the methylated degree of zinc-finger protein 545 (ZNF545) DNA promoter in gastric cancer.
Deng J; Liang H; Ying G; Dong Q; Zhang R; Yu J; Fan D; Hao X
Oncotarget; 2015 Feb; 6(6):4482-95. PubMed ID: 25714013
[TBL] [Abstract][Full Text] [Related]
7. Methylation of ASC/TMS1 promoter is associated with poor prognosis of patients with gastric cancer.
Wu L; Zhang C; Wang X; Ding X; Deng J; Liang H
Clin Transl Oncol; 2016 Mar; 18(3):296-303. PubMed ID: 26260914
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the clinical feasibility: The direct bisulfite genomic sequencing for examination of methylated status of E3 ubiquitin ligase RNF180 DNA promoter to predict the survival of gastric cancer.
Xie XM; Deng JY; Hou YC; Cui JL; Wu WP; Ying GG; Dong QP; Hao XS; Liang H
Cancer Biomark; 2015; 15(3):259-65. PubMed ID: 25769451
[TBL] [Abstract][Full Text] [Related]
9. DACT1, an antagonist to Wnt/β-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer.
Yin X; Xiang T; Li L; Su X; Shu X; Luo X; Huang J; Yuan Y; Peng W; Oberst M; Kelly K; Ren G; Tao Q
Breast Cancer Res; 2013 Mar; 15(2):R23. PubMed ID: 23497530
[TBL] [Abstract][Full Text] [Related]
10. Methylation of ras association domain protein 10 (RASSF10) promoter negative association with the survival of gastric cancer.
Deng J; Liang H; Ying G; Li H; Xie X; Yu J; Fan D; Hao X
Am J Cancer Res; 2014; 4(6):916-23. PubMed ID: 25520879
[TBL] [Abstract][Full Text] [Related]
11. Methylation of CpG sites in RNF180 DNA promoter prediction poor survival of gastric cancer.
Deng J; Liang H; Ying G; Zhang R; Wang B; Yu J; Fan D; Hao X
Oncotarget; 2014 May; 5(10):3173-83. PubMed ID: 24833402
[TBL] [Abstract][Full Text] [Related]
12. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
13. The survival decrease in gastric cancer is associated with the methylation of B-cell CLL/lymphoma 6 member B promoter.
Deng J; Liang H; Dong Q; Hou Y; Xie X; Yu J; Fan D; Hao X
Open Biol; 2014 Jul; 4(7):. PubMed ID: 25008234
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
Guo YL; Shan BE; Guo W; Dong ZM; Zhou Z; Shen SP; Guo X; Liang J; Kuang G
J Biomed Sci; 2017 Jan; 24(1):6. PubMed ID: 28077137
[TBL] [Abstract][Full Text] [Related]
15. Identification of High-Frequency Methylation Sites in RNF180 Promoter Region Affecting Expression and Their Relationship with Prognosis of Gastric Cancer.
Han F; Liu S; Jing J; Li H; Yuan Y; Sun LP
Cancer Manag Res; 2020; 12():3389-3399. PubMed ID: 32494203
[TBL] [Abstract][Full Text] [Related]
16. Effects of DACT1 methylation status on invasion and metastasis of nasopharyngeal carcinoma.
Yang JH; Lin LK; Zhang S
Biol Res; 2019 Jun; 52(1):31. PubMed ID: 31182157
[TBL] [Abstract][Full Text] [Related]
17. KCNMA1 cooperating with PTK2 is a novel tumor suppressor in gastric cancer and is associated with disease outcome.
Ma G; Liu H; Hua Q; Wang M; Du M; Lin Y; Ge Y; Gong W; Zhao Q; Qiang F; Tao G; Zhang Z; Chu H
Mol Cancer; 2017 Feb; 16(1):46. PubMed ID: 28231797
[TBL] [Abstract][Full Text] [Related]
18. Site-specific Hypermethylation of RUNX3 Predicts Poor Prognosis in Gastric Cancer.
Wang N; Sui F; Ma J; Su X; Liu J; Yao D; Shi B; Hou P; Yang Q
Arch Med Res; 2016 May; 47(4):285-92. PubMed ID: 27664488
[TBL] [Abstract][Full Text] [Related]
19. Promoter methylation of RNF180 is associated with H.pylori infection and serves as a marker for gastric cancer and atrophic gastritis.
Han F; Sun LP; Liu S; Xu Q; Liang QY; Zhang Z; Cao HC; Yu J; Fan DM; Nie YZ; Wu KC; Yuan Y
Oncotarget; 2016 Apr; 7(17):24800-9. PubMed ID: 27050149
[TBL] [Abstract][Full Text] [Related]
20. Profile of methylated CpG sites of hMLH1 promoter in primary gastric carcinoma with microsatellite instability.
Kang GH; Lee S; Shim YH; Kim JC; Ro JY
Pathol Int; 2002 Dec; 52(12):764-8. PubMed ID: 12588445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
